PET/CT with 18F-FDG in Eosinophilic Fasciitis. Clinical Case
https://doi.org/10.37174/2587-7593-2022-5-2-76-80
Abstract
Purpose: Assessment of PET capabilities in the diagnosis of eosinophilic fasciitis.
Material and methods: A 37-year-old patient with complaints of subfebrile temperature, weight loss, swelling of the lower extremities, difficulty in movement in the knee joints underwent PET/CT with 18F-FDG to exclude paraneoplastic syndrome. According to the results of PET/CT, laboratory tests and anamnesis, eosinophilic fasciitis was suspected. A deep biopsy of the skin, muscles, fascia of the left shoulder was performed. Localization was chosen taking into account the convenience of anatomical access for biopsy, based on the highest values of accumulation of 18F-FDG. According to the results of morphological examination, the diagnosis of eosinophilic fasciitis was confirmed.
Conclusion: PET/CT made it possible, together with clinical and laboratory data, to assume the diagnosis of eosinophilic fasciitis, excluding paraneoplastic syndrome, and also to determine the optimal area for biopsy.
About the Authors
P. E. Tulin
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24 Kashirskoye Highway, Moscow, 115478
A. A. Odzharova
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24 Kashirskoye Highway, Moscow, 115478
M. A. Belyakova
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24 Kashirskoye Highway, Moscow, 115478
A. S. Krylov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
24 Kashirskoye Highway, Moscow, 115478
References
1. Torres V, George W. Diffuse eosinophilic fasciitis. A new syndrome or variant of Scleroderma? Arch Derm. 1977;113(11):1591-3. DOI: 10.1001/archderm.1977.01640110111021
2. Lebeaux D, Frances C, Barete S, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology. 2011;51(3):557-61. DOI: 10.1093/rheumatology/ker366
3. Erez D, Shoenfeld Y, Natour A, et al. Clinical experience with biologic treatment in resistant eosinophilic fasciitis. Medicine (Baltimore). 2021;100(13):e25359. DOI: 10.1097/md.0000000000025359
4. Bachmeyer C, Monge M, Dhôte R, et al. Eosinophilic Fasciitis following Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia and Hashimoto’s Disease. Dermatology. 1999;199(3):282-2. DOI: 10.1159/000018271
5. Farrell AM, Ross JS, Bunker CB. Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines. Br J Dermatol. 1999;140(6):1185-7. DOI: 10.1046/j.1365-2133.1999.02909.x
6. Lakhanpal S, Ginsburg W, Michet C, et al. Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988;17(4):221-31. DOI: 10.1016/0049-0172(88)90008-x
7. Dybowski F, Neuen-Jacob E, Braun J, et al. Eosinophilic fasciitis and myositis: use of imaging modalities for diagnosis and monitoring. Ann Rheum Dis. 2008;67(4):572-4. DOI: 10.1136/ard.2007.076844
8. Wright N, Mazori D, Patel M. Epidemiology and Treatment of Eosinophilic Fasciitis. JAMA Dermatol. 2016;152(1):97. DOI: 10.1001/jamadermatol.2015.3648
9. Mazori D, Femia A, Vleugels R. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep. 2017;19(12):74. DOI: 10.1007/s11926-017-0700-6
10. Heidary N, Cheung W, Wang N, et al. Eosinophilic fasciitis/generalized morphea overlap. Dermatol Online J. 2009;15(8):2. DOI: 10.5070/d36148k6d0
11. Sugimoto T, Nitta N, Kashiwagi A. Usefulness of magnetic resonance imaging in eosinophilic fasciitis. Rheumatology International. 2007;27(8):791-2. DOI: 10.1007/s00296-006-0302-5
12. Salman A, Ergun T, Seckin D, et al. Atypical presentations of eosinophilic fasciitis. Indian Journal of Dermatology, Venereology, and Leprology. 2016;82(1):47. DOI: 10.4103/0378-6323.171010
13. Kirchgesner T, Dallaudière B, Omoumi P, et al. Eosinophilic fasciitis: Typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging. Diagn Interv Imaging. 2015;96(4):341-8. DOI: 10.1016/j.diii.2014.06.018
14. Baumann F, Brühlmann P, Andreisek G, et al. MRI for Diagnosis and Monitoring of Patients with Eosinophilic Fasciitis. Ame J Roentgenol. 2005;184(1):169-74. DOI: 10.2214/ajr.184.1.01840169
15. Chan V, Soans B, Mathers D. Ultrasound and magnetic resonance imaging features in a patient with eosinophilic fasciitis. Australas Radiol. 2004;48(3):414-7. DOI: 10.1111/j.0004-8461.2004.01331.x
16. Mondal S, Goswami R, Sinha D, et al. Ultrasound is a useful adjunct in diagnosis of eosinophilic fasciitis. Rheumatology. 2015;54(11):2041. DOI: 10.1093/rheumatology/kev290
17. Au Eong D, Cronin O, Biswas A, et al. Ultrasound in the diagnosis and monitoring of eosinophilic fasciitis. Rheumatology. 2020;60(3):107-8. DOI: 10.1093/rheumatology/keaa498
18. Barlet J, Virone A, Gomez L, et al. 18F-FDG PET/ CT and MRI findings of Shulman syndrome also known as eosinophilic fasciitis. Eur J Nucl Med Mol Imaging. 2021;48(6):2049-50. DOI: 10.1007/s00259-020-05172-4
19. Belfeki N, Louarn N, Chouchane A, et al. The place of 18F-FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report. 2020;72(4):252-4. DOI: 10.4081/reumatismo.2020.1353.
20. Marie I, Sauvetre G. Fluorodeoxyglucose positron emission tomography in eosinophilic fasciitis. Joint Bone Spine. 2014;81(6):541. DOI: 10.1016/j.jbspin.2014.07.001
21. Kim H, Lee S, Kim G, et al. Usefulness of FDG PET/CT in the Diagnosis of Eosinophilic Fasciitis. Clin Nucl Med. 2014;39(9):801-2. DOI: 10.1097/rlu.0000000000000260
Review
For citations:
Tulin P.E., Odzharova A.A., Belyakova M.A., Krylov A.S. PET/CT with 18F-FDG in Eosinophilic Fasciitis. Clinical Case. Journal of oncology: diagnostic radiology and radiotherapy. 2022;5(2):76-80. (In Russ.) https://doi.org/10.37174/2587-7593-2022-5-2-76-80
Views:
333
Email this article 